At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
Does this inspire you and feel like a fit? Then we would love to have you join us!
The RoleThe Associate Director, Medical Affairs Strategy, Oncology will lead the medical strategy and tactical planning for assigned assets or therapeutic areas within France, translating European and global priorities into plans that address local scientific needs.
Reporting to the Country Medical Director, the role will lead asset-level medical launch readiness, identify local evidence needs and coordinate cross-functional delivery of the medical plan. The incumbent will work closely with the MSL team to ensure effective field execution and that insights from external engagement inform medical priorities.
Within the operating model, the Country Medical Director owns the overall country medical strategy, organisation and budget. The Associate Director leads strategy for assigned assets or therapeutic areas.
Key ResponsibilitiesMedical Strategy and Planning- Develop and deliver country medical strategic and tactical plans for assigned assets, aligned with European and global priorities.
- Translate scientific insights, unmet needs and evidence gaps into clear objectives, activities and measures of impact.
- Serve as the medical subject matter expert on relevant cross-functional brand and launch teams.
- Work with Clinical Development, Regulatory, Market Access and Commercial colleagues to contribute medical input to launch and lifecycle planning.
- Develop activity budgets and manage approved expenditure under the oversight of the Country Medical Director.
- Partner with European/Global Medical Affairs Strategy Leads to ensure alignment and communicate country priorities.
Medical Launch Readiness and Execution- Lead pre-launch, launch and post-launch medical planning and readiness for assigned assets.
- Coordinate delivery of medical activities, including advisory boards, scientific education, congress plans and medical materials.
- Partner with the MSL team to translate medical strategy into field plans and provide the scientific direction and resources needed for execution.
- Collaborate with Medical Affairs Training to support scientific readiness across relevant teams.
- Monitor progress against agreed objectives and adapt plans in response to insights, emerging data and changing needs.
Evidence Planning and Clinical Development Input- Lead the identification and prioritisation of country evidence needs and contribute these to European and global evidence-generation plans.
- Partner with Global evidence-generation teams on the design and delivery of agreed initiatives, within established governance.
- Provide country medical input into global clinical development strategy, study design and feasibility.
- Support locally led studies where agreed, with responsibilities defined through the relevant governance.
- Evaluate and facilitate investigator-sponsored research proposals through established review processes.
Scientific Engagement and Insights- Build relationships with relevant thought leaders, investigators, scientific societies and patient advocacy organisations.
- Lead strategic scientific engagement to understand clinical practice, unmet needs and evidence gaps.
- Act as a scientific expert at advisory boards, congresses and other appropriate forums.
- Integrate field insights with other scientific and healthcare-system information to inform medical decisions.
Governance and Collaboration- Ensure scientific accuracy, balance and alignment of medical materials with global and local strategy.
- Contribute to material review and approval within assigned responsibilities and local requirements.
- Collaborate with Medical Information, Pharmacovigilance, Legal, Compliance and Regulatory colleagues.
- Ensure all activities follow applicable requirements, industry codes and Genmab policies.
Requirements- Advanced degree in medicine, pharmacy or life sciences, such as an MD, PharmD or PhD.
- At least 8+ years of experience in Medical Affairs, Clinical Development or a related role.
- Relevant oncology experience strongly preferred.
- Experience developing and executing medical plans; launch experience preferred.
- Strong scientific expertise and ability to critically interpret clinical data.
- Understanding of the local healthcare system, treatment pathways and payer landscape.
- Significant experience working on clinical trial methodology and conduct of registries, early access programs and IST programs in oncology
- Experience working effectively across local, regional and global teams.
- Strong planning, communication and stakeholder engagement skills.
- Fluency in English and French
Competencies and Attributes- Strategic and analytical thinking, with the ability to translate priorities into practical plans.
- Scientific curiosity and a patient-focused approach.
- Collaborative working style and ability to influence without direct authority.
- Sound judgement, integrity and accountability.
- Ability to prioritise and adapt within a growing organisation.
Location and TravelBased in France, with regular office presence (typically three days per week) and domestic and international travel for scientific engagement, congresses and internal collaboration.
The proposed gross annual base salary range for this position, in the primary location, based on a full time schedule is:
EUR85.600,00---128.400,00
The final salary offer will depend on several factors, including your skills, qualifications, and experience.
In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.
When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:
- Pension
- Health insurance and wellness benefits
- Paid time off
- Employee support programs
Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.
About GenmabGenmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on
LinkedIn and
X.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website
Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.